Jimmy Lin, Molly Kinder, and Brandon Rickabaugh join CCPL's Director of Research, Alex Arnold, for a panel on the future of Artificial Intelligence at the 2025 For the Good of the Public Summit.

Molly Kinder is a fellow at Brookings Metro, where she leads their Artificial Intelligence and Emerging Technology Initiative project.

C. Jimmy Lin, MD, PhD, MHS, MAR is the Chief Scientific Officer at Freenome - a cancer diagnostic biotech in the SF Bay Area.

Dr. Brandon Rickabaugh, an award-winning author and former philosophy professor, is the founder of NOVUS, where he explores questions about human consciousness, knowledge, emotion, and virtue formation.